Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-2242
Full Text
Open PDFAbstract
Available in full text
Date
April 7, 2009
Authors
Publisher
American Association for Cancer Research (AACR)